ID NPAT_MOUSE Reviewed; 1420 AA. AC Q8BMA5; Q8BWA9; Q8BY06; DT 05-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 05-FEB-2008, sequence version 2. DT 27-MAR-2024, entry version 127. DE RecName: Full=Protein NPAT; GN Name=Npat; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Cerebellum, Head, and Muellerian duct; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP FUNCTION. RX PubMed=9199343; DOI=10.1128/mcb.17.7.4080; RA Di Fruscio M., Weiher H., Vanderhyden B.C., Imai T., Shiomi T., Hori T., RA Jaenisch R., Gray D.A.; RT "Proviral inactivation of the Npat gene of Mpv 20 mice results in early RT embryonic arrest."; RL Mol. Cell. Biol. 17:4080-4086(1997). RN [4] RP DEVELOPMENTAL STAGE. RX PubMed=12665581; DOI=10.1128/mcb.23.8.2821-2833.2003; RA Gao G., Bracken A.P., Burkard K., Pasini D., Classon M., Attwooll C., RA Sagara M., Imai T., Helin K., Zhao J.; RT "NPAT expression is regulated by E2F and is essential for cell cycle RT progression."; RL Mol. Cell. Biol. 23:2821-2833(2003). RN [5] RP SUBCELLULAR LOCATION. RX PubMed=17003125; DOI=10.1073/pnas.0604227103; RA Barcaroli D., Bongiorno-Borbone L., Terrinoni A., Hofmann T.G., Rossi M., RA Knight R.A., Matera A.G., Melino G., De Laurenzi V.; RT "FLASH is required for histone transcription and S-phase progression."; RL Proc. Natl. Acad. Sci. U.S.A. 103:14808-14812(2006). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-598 AND SER-1249, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Kidney, Lung, and Spleen; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Required for progression through the G1 and S phases of the CC cell cycle and for S phase entry. Activates transcription of the CC histone H2A, histone H2B, histone H3 and histone H4 genes in CC conjunction with MIZF. Also positively regulates the ATM, MIZF and CC PRKDC promoters. Transcriptional activation may be accomplished at CC least in part by the recruitment of the NuA4 histone acetyltransferase CC (HAT) complex to target gene promoters (By similarity). Required for CC early embryonic development. {ECO:0000250, ECO:0000269|PubMed:9199343}. CC -!- SUBUNIT: Interacts with the cylin/CDK complexes CCNE1/CDK2 and CC CCNA1/CDK2. Interacts with BZW1, CASP8AP2, CREBBP, MIZF and YY1. CC Interacts with the RUVBL1, RUVBL2 and TRRAP subunits of the NuA4 CC complex. May also interact with GAPDH, NME1, NME2 and STIP1 (By CC similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17003125}. CC Note=Concentrates in Cajal bodies tethered to histone gene clusters. CC {ECO:0000250}. CC -!- DEVELOPMENTAL STAGE: Expression peaks at the G1/S phase boundary. CC {ECO:0000269|PubMed:12665581}. CC -!- DOMAIN: The LisH domain is required for the activation of histone gene CC transcription. {ECO:0000250}. CC -!- PTM: Phosphorylated at Ser-771, Ser-773, Ser-1096, Thr-1264 and Thr- CC 1343 by CCNE1/CDK2 at G1-S transition and until prophase, which CC promotes association with histone gene clusters and stimulates CC activation of histone transcription. Also phosphorylated by CCNA1/CDK2 CC in vitro (By similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the NPAT family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK033012; BAC28125.1; -; mRNA. DR EMBL; AK042624; BAC31308.1; -; mRNA. DR EMBL; AK053074; BAC35255.1; -; mRNA. DR EMBL; AC156640; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS40637.1; -. DR RefSeq; NP_001074621.1; NM_001081152.1. DR AlphaFoldDB; Q8BMA5; -. DR SMR; Q8BMA5; -. DR BioGRID; 232697; 3. DR STRING; 10090.ENSMUSP00000048709; -. DR iPTMnet; Q8BMA5; -. DR PhosphoSitePlus; Q8BMA5; -. DR EPD; Q8BMA5; -. DR jPOST; Q8BMA5; -. DR MaxQB; Q8BMA5; -. DR PaxDb; 10090-ENSMUSP00000048709; -. DR PeptideAtlas; Q8BMA5; -. DR ProteomicsDB; 293946; -. DR Pumba; Q8BMA5; -. DR Antibodypedia; 45544; 51 antibodies from 12 providers. DR Ensembl; ENSMUST00000035850.8; ENSMUSP00000048709.8; ENSMUSG00000033054.8. DR GeneID; 244879; -. DR KEGG; mmu:244879; -. DR UCSC; uc009pmf.1; mouse. DR AGR; MGI:107605; -. DR CTD; 4863; -. DR MGI; MGI:107605; Npat. DR VEuPathDB; HostDB:ENSMUSG00000033054; -. DR eggNOG; ENOG502QYUR; Eukaryota. DR GeneTree; ENSGT00390000012388; -. DR HOGENOM; CLU_004845_0_0_1; -. DR InParanoid; Q8BMA5; -. DR OMA; CFDNVLP; -. DR OrthoDB; 2917859at2759; -. DR PhylomeDB; Q8BMA5; -. DR TreeFam; TF332825; -. DR BioGRID-ORCS; 244879; 26 hits in 80 CRISPR screens. DR ChiTaRS; Npat; mouse. DR PRO; PR:Q8BMA5; -. DR Proteomes; UP000000589; Chromosome 9. DR RNAct; Q8BMA5; Protein. DR Bgee; ENSMUSG00000033054; Expressed in manus and 226 other cell types or tissues. DR GO; GO:0015030; C:Cajal body; ISS:UniProtKB. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0097504; C:Gemini of coiled bodies; ISS:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB. DR GO; GO:0005634; C:nucleus; ISO:MGI. DR GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB. DR GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central. DR GO; GO:0003714; F:transcription corepressor activity; ISO:MGI. DR GO; GO:0044843; P:cell cycle G1/S phase transition; ISO:MGI. DR GO; GO:0001701; P:in utero embryonic development; IMP:MGI. DR GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:MGI. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI. DR InterPro; IPR006594; LisH. DR InterPro; IPR031442; NPAT_C. DR PANTHER; PTHR15087; PROTEIN NPAT; 1. DR PANTHER; PTHR15087:SF14; PROTEIN NPAT; 1. DR Pfam; PF15712; NPAT_C; 1. DR SMART; SM00667; LisH; 1. DR PROSITE; PS50896; LISH; 1. DR Genevisible; Q8BMA5; MM. PE 1: Evidence at protein level; KW Acetylation; Activator; Cell cycle; Isopeptide bond; Nucleus; KW Phosphoprotein; Reference proteome; Transcription; KW Transcription regulation; Ubl conjugation. FT CHAIN 1..1420 FT /note="Protein NPAT" FT /id="PRO_0000318164" FT DOMAIN 3..35 FT /note="LisH" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00126" FT REGION 1..319 FT /note="Interaction with MIZF" FT /evidence="ECO:0000250" FT REGION 5..25 FT /note="Required for activation of histone gene FT transcription and interaction with MIZF" FT /evidence="ECO:0000250" FT REGION 121..145 FT /note="Required for activation of histone gene FT transcription and interaction with MIZF" FT /evidence="ECO:0000250" FT REGION 179..236 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 263..339 FT /note="Mediates transcriptional activation" FT /evidence="ECO:0000250" FT REGION 534..612 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 625..670 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 628..652 FT /note="Required for acceleration of G1 phase" FT /evidence="ECO:0000250" FT REGION 696..727 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 822..847 FT /note="Required for acceleration of G1 phase" FT /evidence="ECO:0000250" FT REGION 1033..1048 FT /note="Required for acceleration of G1 phase" FT /evidence="ECO:0000250" FT REGION 1089..1190 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1202..1234 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1223..1247 FT /note="Required for acceleration of G1 phase" FT /evidence="ECO:0000250" FT REGION 1249..1297 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1319..1342 FT /note="Required for acceleration of G1 phase" FT /evidence="ECO:0000250" FT REGION 1348..1400 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 179..212 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 220..236 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 534..604 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 633..661 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1156..1176 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1268..1286 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1359..1376 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 209 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT MOD_RES 552 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT MOD_RES 598 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 771 FT /note="Phosphoserine; by CDK2" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT MOD_RES 773 FT /note="Phosphoserine; by CDK2" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT MOD_RES 1096 FT /note="Phosphoserine; by CDK2" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT MOD_RES 1146 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT MOD_RES 1223 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT MOD_RES 1249 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 1264 FT /note="Phosphothreonine; by CDK2" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT MOD_RES 1343 FT /note="Phosphothreonine; by CDK2" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT CROSSLNK 1112 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT CROSSLNK 1144 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT CROSSLNK 1274 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q14207" FT CONFLICT 1141 FT /note="S -> P (in Ref. 1; BAC35255)" FT /evidence="ECO:0000305" SQ SEQUENCE 1420 AA; 152176 MW; 1035459489343314 CRC64; MLLPSDVARL VLGYLQQENL TSTCQTFILE SSNLKEYAEH CTDEGFIPAC LLSLFGKNLT TILNEYVAMK AKETSNDVPT IMSSLWKKLD HTLSQIRSMH SSPGFAAHQR ARTRNGIAEI KRQRWLASQA APVSSELLVL PYASGQFTTS PLVATQAVKP TGPISTPVRS NIVVVNQSQP QSTVTNTAGE SLNIIPGPQE RKTQTSLMSP GRRKSESQKK SLTSSGPHSS RNFQDPNAFA VEKQMVIENA REKILSNKSL QEKLAENINK FLTSDSSVAQ VPKQTDSNPT EPETSIDELL GLPSEIHMSE EAIQDILEQT ESDPAFQALF DLFDYGKTKN NKNMPQISSQ PMETNSNIVL PEETNLTIKS SFETEESDGQ SGQPPFCTSY QNEDVLLNDL KSGNSHDVLP QESQENFSQI SSNIQKKTFK TAIPAEQKCA LDITLESVSN LSDFNQRGSS AECNEHCSEL FASQIPTEAE VAVGEKNSLS ADILSQSQYQ PDQPSVPVTS FVSLGGETND KNLVLSGKNS QLLSQSTPLT TKPSKSQLCE NSNNIIKVKT NPQASESADS SETANRKTET NTVSPAAAQP QADCQDNSPL QSKPPPGIGE SLGVNVTEKI EIHLEEPAPS DKQLSNDAAS VDLNPTESKT EPLQSASAQE PEPPSVKDGD TIFLSLSEHN SCEEVALVLG EGNPVKNNNS LSSESGGSVG VSPETQNTDG KTSNSTEVDA SSIVSLKIII SDDPFVSSDA ELNSAVSSIS GENLPTIILS SKSPAKNAEF VTCLSSEETA SAVVSVEVGD SGSMEQNLLV LKPEEPMVNN TQNEDGIAFS ANVAPCVPKD GGYIQLMPTT STAFGNSSNI LIATCMTDST ALGPTVSQSN VVVLPGSSAP MTAQPPQQQL QTPPKSNSAF AVSQAVSPNF SQGSAIIIAS PVQPVLQGMV GMIPVSVVGQ NGNTFSTPPQ QVLHMPLAAP VCNRSIAQLP IPQKSQKAQG LRNKLITGKQ VNNLTNLSSL SEACHTQRTE ASDKNIATEL GKKMEDTTIS LSGERVAPPS KPFESHRRVL CFDSTVSSVA NTQGSLYKMT SENKEKKEAS FSHLDSPILS STLKPPPNNA IKREREKTVP KILSKSETAS SRHTTVKEVQ SEKKVSPTEV ALESLHKATA NKENELCGDG ERPKNADTSK LPGGQQNGSL RNEKAIASLQ ELTKKQATPS NNKNATSVGG TVKDQKQEQS KPASSLIGAE ILQDVPIHSP ANRSADTDLP VPRTPGSGAG EKHKEEPSDS MKAPASRRCG EEGSMPRVMI PPVTADLPAC SPASETGSEN SVSMAAHTLM ILSRAAIART TATPLKDNTQ QFRTSSRSTT KKRKIEELDE CERNSRTSGK NLANSSVPMK KKKIKKKKLP SSFPAGMDVD KFLLSLHYDE //